IDT Biologika has acquired Gallant Custom Laboratories, based in Ontario, Canada. Gallant is authorized by the Canadian Food Inspection Agency (CFIA) to manufacture autogenous viral and bacterial vaccines.   “With its strong scientific focus, in-house research and development and production of autogenous vaccines for the Canadian market, Gallant is an outstanding match for the IDT Group,” said IDT Biologika CEO Dr. Ralf Pfirmann. “With this second acquisition in North America...